Key Highlights

  • Medibank Private Limited reported FY26 statutory net profit of AUD 638.7 million, increasing 27.5%.
  • Underlying net profit increased 2.9% to AUD 636.8 million, supported by insurance and health services.
  • Medibank Health segment profit increased 31.3% to AUD 100.7 million, reflecting Business expansion.
  • FY27 outlook anticipates approximately 25% growth in Medibank Health profit, including Better Medical's contribution.

Medibank Private Limited (ASX:MPL), one of Australia's largest private Health Insurance providers, is approaching its Annual General Meeting on 18 November 2026 with a growing contribution from healthcare services alongside its established insurance operations. The company's FY26 financial results showed higher statutory and underlying profitability, supported by customer growth, improved operating performance and expansion across its Medibank Health division. However, increasing operating expenses, pressure on insurance affordability and ongoing legal proceedings associated with the 2022 cybercrime incident remain important considerations for its FY27 outlook.

The company released its financial results for the year ended 30 June 2026 on 20 August 2026, reporting statutory net profit after tax of AUD 638.7 million, compared with AUD 500.8 million in FY25.

Underlying net profit after tax increased by 2.9% to AUD 636.8 million, reflecting more moderate growth in recurring Earnings than the statutory result suggested.

Meanwhile, group operating profit increased by 6.7% to AUD 813.5 million, supported by contributions from both Health Insurance and Medibank Health.

The company also maintained its focus on customer acquisition, Investment in healthcare delivery and improvements in operational efficiency.

Looking ahead, Medibank expects further expansion in its health services business, while its insurance operations remain influenced by medical claims costs, customer Demand and government-regulated premium increases.

Understanding Medibank's Health Insurance and Healthcare Services Business

Medibank operates across private health insurance, healthcare services and related health and wellbeing activities in Australia.

Its principal insurance brands are Medibank and ahm.

The Medibank Brand provides a broad range of private health insurance products, including hospital cover, extras cover and combined insurance packages.

The ahm brand focuses on accessible health insurance products, particularly for customers seeking different levels of coverage and pricing.

Together, the brands serve a substantial portion of Australia's private health insurance market.

Medibank also provides health insurance products for non-resident customers, including international students, temporary workers and other eligible visa holders.

The group serves more than six million people through its insurance and healthcare operations.

In addition to insurance, Medibank operates healthcare delivery businesses through its Medibank Health division, including Amplar Health and primary care operations.

These activities cover virtual healthcare, home-based care, general practice services and selected specialist healthcare services.

The division includes the Better Medical business, which expanded Medibank's primary care network.

Medibank generates Revenue primarily through health insurance premiums and payments for healthcare services.

Its profitability depends on insurance membership, premium income, medical claims expenses, operating costs and earnings from healthcare delivery.

The expansion of healthcare services is intended to diversify the company's revenue streams while supporting customer access to healthcare beyond traditional insurance products.

FY26 Financial Results Reflect Higher Group Profitability

For the financial year ended 30 June 2026, Medibank reported net profit after tax attributable to shareholders of AUD 638.7 million, compared with AUD 500.8 million in FY25.

This represented an increase of approximately 27.5%.

However, the statutory comparison was affected by changes in non-recurring expenses, including costs associated with the 2022 cybercrime incident.

Underlying net profit after tax increased by 2.9% to AUD 636.8 million, compared with AUD 618.7 million in FY25.

Underlying earnings provide a measure of recurring financial performance after adjusting for selected non-recurring items.

Group operating profit increased by 6.7% to AUD 813.5 million, compared with approximately AUD 762.4 million in the preceding financial year.

The improvement reflected higher earnings across Health Insurance and Medibank Health.

Health Insurance operating profit increased by 3.8% to AUD 769.8 million, compared with AUD 741.5 million in FY25.

Meanwhile, Medibank Health recorded segment profit of AUD 100.7 million, representing growth of 31.3% from AUD 76.7 million.

These results highlight the increasing contribution of healthcare delivery services to the group's overall operating performance.

However, Health Insurance remains Medibank's principal earnings contributor, meaning membership trends, premium revenue and claims expenses continue to influence group profitability.

Resident Health Insurance Premium Revenue Increases 4.5%

Medibank's resident private health insurance business recorded premium revenue of AUD 8,267.9 million during FY26.

This represented an increase of approximately 4.5% compared with the preceding financial year.

Revenue growth reflected premium adjustments and an increase in resident policyholders.

Net resident policyholder growth reached 22,100 during the year, representing an increase of approximately 1.1%.

The Medibank brand added 8,600 resident policyholders, while ahm contributed an additional 13,500 policyholders.

The higher contribution from ahm demonstrates continued customer demand for alternative health insurance products.

Private health insurance customers generally select policies based on premium affordability, coverage requirements, hospital access and the availability of additional benefits.

Medibank's two-brand strategy allows the company to serve different customer segments within the Australian insurance market.

The Medibank brand offers a broad selection of hospital and extras products, while ahm provides a different product and pricing proposition.

Customer growth is important because additional policyholders can increase premium revenue and improve the scale of insurance operations.

However, the financial contribution from new policyholders depends on premium levels, claims expenses, Acquisition costs and customer retention.

Medibank continues investing in customer engagement, product development and service improvements to support membership growth.

Non-Resident Insurance Business Faces Membership Pressure

Medibank's non-resident health insurance operations experienced a reduction in policy units during FY26.

The number of non-resident policy units declined by approximately 2.3% to 346,200.

This reflected changes in demand from international students and other temporary residents.

Australia's migration and international education settings influence the number of eligible customers requiring health insurance coverage.

International students generally require Overseas Student Health Cover, while certain temporary visa holders purchase Overseas Visitors Health Cover.

Changes in visa approvals, student enrolments and migration arrangements can therefore influence non-resident insurance membership.

The decline in policy units demonstrates the sensitivity of this business to government policy and international mobility.

However, Medibank continues focusing on premium management, product development and customer retention within its non-resident portfolio.

The company expects non-resident Gross Profit to increase during FY27, despite the membership challenges experienced in FY26.

This expectation reflects management's assessment of premium income, claims costs and other operating factors.

Actual performance will depend on customer volumes, pricing arrangements and changes in migration-related demand.

Medibank Health Delivers 31.3% Profit Growth

Medibank Health represented one of the group's faster-growing operating divisions during FY26.

Segment profit increased by 31.3% to AUD 100.7 million, compared with AUD 76.7 million in FY25.

The division contributed approximately 12% of group operating profit, reflecting its increasing importance within Medibank's business structure.

Growth was supported by the expansion of primary care, virtual healthcare and other health service activities.

Medibank has invested in healthcare delivery models intended to provide patients with additional Options for receiving medical services.

These include healthcare delivered in homes, community settings, medical centres and through digital consultations.

The company's strategy reflects changes in healthcare demand as patients and providers increasingly consider alternatives to traditional hospital-based treatment.

Home-based and community healthcare services can support selected patients who do not require continuous hospital care.

Medibank Health also provides services through partnerships with healthcare organisations and other payers.

This allows the division to generate revenue from customers and organisations beyond Medibank's existing insurance membership.

The expansion of healthcare services provides an additional source of operating earnings, although profitability will depend on service volumes, labour costs, clinical quality and integration expenditure.

Better Medical Acquisition Supports Primary Care Expansion

The acquisition of Better Medical represents an important component of Medibank's healthcare services strategy.

Better Medical operates a network of general practice clinics and related primary healthcare services.

The acquisition expanded Medibank's presence in primary care and increased its ability to provide healthcare services directly to patients.

Primary care plays an important role in preventive healthcare, early diagnosis and the management of ongoing medical conditions.

Through its expanded network, Medibank aims to improve coordination between insurance, general practice and other healthcare services.

The Better Medical acquisition also provides opportunities to expand virtual general practitioner services and integrate additional healthcare programmes.

During FY26, Medibank progressed the integration of Better Medical into its broader healthcare operations.

The company also expanded virtual GP services for eligible Medibank customers during the financial year.

Virtual consultations can provide patients with additional access to healthcare professionals, particularly where in-person appointments are less convenient.

However, the financial contribution from the acquisition will depend on integration progress, patient demand, workforce availability and operating costs.

Medibank expects the inclusion of a full year of Better Medical earnings to support Medibank Health's FY27 profit growth.

Healthcare Delivery Expands Beyond Traditional Insurance

Medibank continues developing healthcare services that extend beyond conventional private health insurance.

Through Amplar Health and related businesses, the group provides services including virtual care, home-based treatment, preventive healthcare and community health programmes.

These activities are intended to support patients across different stages of their healthcare journey.

Home-based care programmes can allow eligible patients to receive selected treatments outside traditional hospital environments.

The availability of these services depends on medical suitability, clinical supervision and relevant healthcare arrangements.

Medibank also works with healthcare providers to develop alternative care models.

These partnerships can support healthcare delivery in community settings and provide additional options for patients requiring ongoing treatment.

The company has committed investment towards healthcare models that support the transition from hospital-based services to other appropriate care settings.

During FY26, Medibank continued expanding its healthcare delivery network and investing in technology to improve service coordination.

These initiatives form part of the company's longer-term strategy to participate more broadly in Australia's healthcare system.

However, operating performance will depend on the scale of service adoption, clinical workforce capacity and the effectiveness of partnerships.

Operating Expenses Increase Alongside Customer Investment

Medibank reported operating expenses of AUD 690.2 million during FY26.

This represented an increase of approximately 5.4% compared with FY25.

The increase reflected investment in customer acquisition, brand development, technology and customer reward programmes.

Despite higher total expenses, the company's expense ratio remained at approximately 8.0%.

The expense ratio measures operating expenses relative to the relevant insurance revenue base.

Maintaining the ratio while increasing expenditure indicates that operating costs remained broadly aligned with business activity.

Medibank also implemented productivity initiatives intended to improve operational efficiency.

These measures included changes to internal processes, digital systems and customer servicing arrangements.

Technology investment remains important as the company expands digital healthcare services and develops its insurance platforms.

The group is also investing in artificial intelligence capabilities and data systems to support operational efficiency and customer service.

However, additional technology investment creates implementation expenses and requires appropriate governance.

Medibank continues balancing expenditure on customer growth and business development with its objective of maintaining insurance profitability.

Health Insurance Margins Remain an Important Earnings Driver

Medibank's Health Insurance division generated operating profit of AUD 769.8 million during FY26.

This represented growth of approximately 3.8%, compared with group operating profit growth of 6.7%.

The difference reflected the higher growth rate achieved by Medibank Health.

Insurance profitability depends on the relationship between premium revenue and the cost of medical claims.

Claims expenses can increase because of higher hospital utilisation, rising treatment costs and changes in the types of medical services used by policyholders.

Medibank must also manage operating expenses and customer acquisition costs.

The company's resident gross Margin reflects premium income after accounting for relevant Insurance Claims expenses.

Maintaining this margin is important because even relatively small changes can affect earnings across a large insurance portfolio.

For FY27, Medibank expects resident gross margin to remain broadly consistent with FY26.

However, this outlook is subject to the outcome of the annual private health insurance premium approval process.

The next premium adjustment is scheduled for 1 April 2027.

Changes in approved premium increases, claims Inflation and policyholder demand will influence the eventual margin outcome.

Private Health Insurance Affordability Remains a Sector Challenge

Affordability continues to influence customer decisions across Australia's private health insurance market.

Households face competing financial demands, including housing costs, energy expenses and other everyday expenditure.

These pressures can affect decisions to purchase or maintain private health insurance.

Some customers may choose lower-cost policies, reduce optional coverage or reconsider their insurance arrangements.

At the same time, insurers face increasing medical treatment costs and higher payments to healthcare providers.

This creates a challenge when balancing premium affordability with the cost of providing insurance coverage.

Private health insurance premium increases in Australia require government approval.

Insurers submit proposed premium adjustments for assessment before changes take effect.

The approval process considers factors including claims expenses, operating costs and the broader effect on customers.

For Medibank, the outcome of the April 2027 premium round will be relevant to revenue growth and resident insurance margins.

The company's two-brand approach provides customers with different insurance options, but both brands remain exposed to changing healthcare costs and consumer affordability pressures.

Dividend Payments Increase During FY26

Medibank declared a fully franked final Dividend of 10.9 cents per share for FY26.

This brought total annual dividends to 19.2 cents per share, compared with 18.0 cents in FY25.

The increase represented growth of approximately 6.7%.

The final dividend was paid on 8 October 2026.

Total FY26 dividends represented approximately 83.0% of underlying net profit after tax.

This was within the company's target payout range of 75% to 85%.

The Payout Ratio indicates the proportion of underlying earnings distributed to shareholders.

Medibank's dividend policy is influenced by earnings, Capital requirements, regulatory obligations and investment opportunities.

The company continues balancing distributions with expenditure on healthcare services, technology and acquisitions.

Future dividend decisions will depend on financial performance, available capital and the board's assessment of business requirements.

Capital Position Remains Above the Target Range

Medibank reported a Health Insurance required capital ratio of 13.3% at 30 June 2026.

This was above the company's target range of 10% to 12%.

The capital ratio measures regulatory capital held relative to required capital for the insurance business.

Maintaining appropriate capital reserves is important for meeting insurance obligations and managing financial risks.

The ratio included the effect of an AUD 250 million supervisory capital adjustment imposed by the Australian Prudential Regulation Authority following the 2022 cybercrime incident.

The adjustment requires Medibank to maintain additional capital while addressing identified risk management and technology-related concerns.

This affects the amount of capital available for other purposes.

Medibank's unallocated capital declined by AUD 69.0 million during FY26 to AUD 182.9 million.

The reduction reflected Capital Expenditure associated with acquisitions and other business investment activities.

The company continues maintaining capital resources to support its insurance operations while investing in healthcare services.

Future changes to regulatory capital requirements may influence capital availability and financial flexibility.

Cybercrime-Related Costs Continue to Affect Financial Performance

Medibank continues managing the consequences of the cybercrime incident that occurred in October 2022.

The incident involved unauthorised access to customer information and resulted in regulatory investigations, legal proceedings and additional expenditure on technology and security systems.

During FY26, Medibank recorded approximately AUD 34.9 million in non-recurring cybercrime-related expenses.

These costs primarily related to legal proceedings, Cybersecurity improvements and other incident response activities.

The expenditure was lower than the corresponding amount incurred during FY25.

For FY27, Medibank expects non-recurring cybercrime-related costs to decline to below AUD 20 million.

However, this forecast does not include any additional financial implications that may arise from the outcomes of regulatory investigations or litigation.

The company continues investing in information security, technology infrastructure and risk management systems.

These activities are intended to improve data protection and strengthen the management of cybersecurity risks.

Cybersecurity remains particularly important because health insurers maintain sensitive customer information, including personal and health-related records.

Medibank's ongoing expenditure reflects the importance of maintaining appropriate security controls and regulatory compliance.

Legal Proceedings Related to the 2022 Cyber Incident Remain Ongoing

Medibank continues to face legal proceedings associated with the 2022 cybercrime incident.

These include a customer class action and civil penalty proceedings commenced by the Office of the Australian Information Commissioner.

The proceedings concern matters arising from the unauthorised access to customer information and the company's handling of data protection obligations.

Both proceedings are before the Federal Court of Australia.

During October 2026, the court considered procedural matters relating to the management of the cases.

These included questions concerning the relationship between the proceedings and whether they should be managed together.

The customer class action also involves allegations and claims concerning the impact of the incident on affected individuals.

The proceedings remain subject to the court process.

Any financial consequences will depend on the findings, applicable legal requirements and eventual outcomes.

Medibank continues to address the proceedings while implementing improvements to its cybersecurity and risk management arrangements.

The company has also maintained additional regulatory capital in connection with the incident.

These obligations remain relevant to its operating expenses and financial flexibility.

Customer Growth and Brand Positioning Remain Strategic Priorities

Medibank continues focusing on attracting and retaining customers across its principal insurance brands.

During FY26, resident policyholder growth reached 22,100, supported by contributions from both Medibank and ahm.

The Medibank brand added 8,600 resident policyholders, while ahm added 13,500.

The different growth rates reflect customer demand across insurance products and pricing segments.

Medibank's customer strategy includes improving digital services, offering health and wellbeing benefits and expanding customer rewards.

The company is also developing programmes intended to encourage preventive healthcare and healthier lifestyles.

These initiatives can support customer engagement and provide additional reasons for members to retain their insurance coverage.

However, customer acquisition expenditure increased during FY26, contributing to higher operating expenses.

The financial benefits of customer growth will depend on retention, premium revenue and claims experience.

Medibank continues monitoring these factors while balancing membership expansion with insurance profitability.

FY27 Outlook Highlights Further Health Services Expansion

Medibank expects its health services business to remain an important contributor to earnings growth during FY27.

The company has guided for approximately 25% growth in Medibank Health segment profit.

The outlook includes a full-year earnings contribution from Better Medical.

Additional growth is expected from primary care, virtual healthcare and other health service activities.

The company also anticipates growth in non-resident gross profit during FY27.

However, membership trends will continue to depend on migration settings and demand from international students and temporary residents.

Within resident health insurance, Medibank expects gross margin to remain broadly consistent with FY26.

The final margin outcome will depend partly on the premium changes approved for implementation from 1 April 2027.

Medibank is also assessing acquisition opportunities that could expand its healthcare services network.

Potential investments may support geographic expansion, additional clinical capabilities or new healthcare delivery models.

However, future acquisitions will depend on commercial assessments, available capital and relevant approvals.

Annual General Meeting Scheduled for 18 November 2026

Medibank's 2026 annual general meeting is scheduled for Wednesday, 18 November 2026, at 10:00 am Australian Eastern Daylight Time.

The meeting will take place at Federation Square in Melbourne, with online participation also available.

The event will provide an opportunity for shareholders to review the company's FY26 financial performance and hear management's assessment of strategic priorities.

Key areas of interest include the performance of Medibank Health, resident insurance membership trends and progress with healthcare services expansion.

Management may also discuss operating conditions across private health insurance and developments affecting customer affordability.

The company's FY27 outlook will remain relevant, particularly its expectations for resident gross margin and Medibank Health profit growth.

Another important consideration is the ongoing management of cyber-related legal proceedings and regulatory capital obligations.

The AGM represents an opportunity to assess how Medibank intends to balance insurance profitability, investment in healthcare delivery and capital management during the current financial year.

Key Risks and Operational Considerations

Medibank's financial performance remains exposed to medical claims inflation, regulatory decisions and changing customer demand.

Higher hospital and treatment costs could affect insurance margins if premium revenue does not increase sufficiently to offset claims expenses.

The annual premium approval process introduces uncertainty because insurers cannot independently determine final premium adjustments.

Customer affordability also represents an important consideration, particularly as households respond to higher living costs.

Non-resident insurance membership may remain sensitive to migration policy changes and international student demand.

The expansion of Medibank Health involves operational risks associated with acquisitions, workforce availability and clinical service delivery.

Integrating Better Medical and expanding primary care services require expenditure on technology, staff and operational infrastructure.

Cybersecurity and data protection remain important risks following the 2022 cybercrime incident.

Ongoing litigation and regulatory proceedings could create additional costs or obligations.

The AUD 250 million supervisory capital adjustment also affects the company's available capital resources.

Medibank will need to manage these factors while maintaining profitability and progressing its healthcare services strategy.

What Lies Ahead for Medibank Private Limited in FY27?

Medibank enters FY27 with higher underlying earnings, increased resident insurance membership and an expanding healthcare services division.

The company expects Medibank Health segment profit growth of approximately 25%, including the full-year contribution from Better Medical.

Resident health insurance gross margin is expected to remain broadly consistent with FY26, subject to the outcome of the April 2027 premium round.

The company also expects non-resident gross profit growth despite the membership pressures experienced during FY26.

Healthcare services expansion remains a strategic priority, with continued investment in primary care, virtual healthcare and alternative treatment models.

Management is also assessing acquisition opportunities that could increase the scale and geographic reach of its healthcare operations.

The annual general meeting on 18 November 2026 will provide an opportunity to discuss these priorities and developments affecting the business.

Beyond the AGM, the FY27 half-year results will provide further information regarding insurance profitability, customer growth, healthcare services earnings and operating expenses.

Medibank's future financial performance will depend on maintaining insurance margins, managing medical claims costs and converting healthcare services expansion into recurring earnings growth.

Frequently Asked Questions (FAQs)